Charles E. Richardson - 14 Feb 2022 Form 4 Insider Report for Icosavax, Inc.

Role
SVP, Technical Operations
Signature
s/ Elizabeth Bekiroglu, Attorney-in-Fact for Charles E. Richardson
Issuer symbol
N/A
Transactions as of
14 Feb 2022
Net transactions value
+$62,188
Form type
4
Filing time
16 Feb 2022, 16:22:19 UTC
Previous filing
14 Feb 2022
Next filing
02 Aug 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ICVX Common Stock Options Exercise $55,755 +66,375 +70% $0.8400* 161,200 14 Feb 2022 Direct
transaction ICVX Common Stock Options Exercise $6,433 +6,186 +3.8% $1.04* 167,386 14 Feb 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ICVX Stock Option (Right to Buy) Options Exercise $0 -66,375 -60% $0.000000 43,489 14 Feb 2022 Common Stock 66,375 $0.8400 Direct F1
transaction ICVX Stock Option (Right to Buy) Options Exercise $0 -6,186 -27% $0.000000 16,657 14 Feb 2022 Common Stock 6,186 $1.04 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of the shares subject to the option vested on 9/13/2020, and 1/48th of the shares subject to the option vest monthly thereafter.
F2 25% of the shares subject to the option vested on 1/29/2022, and 1/48th of the shares subject to the option vest monthly thereafter.